One quick test for four major infections could transform screening in africa
NCT ID NCT07170748
First seen Oct 31, 2025 · Last updated Apr 30, 2026 · Updated 27 times
Summary
This study is checking how well a new device called MagIA H3S works for detecting HIV, hepatitis B, hepatitis C, and syphilis at the same time. About 2,950 people in Ivory Coast and Kenya will provide blood samples to see if the device gives accurate results compared to standard lab tests. The goal is to see if this single, point-of-care test can reliably screen for all four infections, which could make testing faster and easier in areas with limited resources.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre de Diagnostic et de Recherche sur le SIDA et les autres Maladies Infectieuses - CHU Treichville
RECRUITINGAbidjan, Côte d’Ivoire
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kenya Medical Research Institute (KEMRI)
RECRUITINGNairobi, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.